Advertisement

Topics

Tissue Regenix CEO excited to soon be selling first products in UK

07:51 EDT 13 Jul 2018 | Proactive Investors

Steve Couldwell, chief executive of Tissue Regenix Group PLC (LON:TRX), caught up with Proactive's Andrew Scott following the appointment of Gareth Hywel Jones as their chief financial officer as well as the big news last month that they've been granted a Human Tissue Authority licence which will allow them to import and distribute their US-made products in the UK market.

The licence will initially be used to import CellRight’s BioRinse portfolio of bone healing products which are made at its Texas manufacturing facility.

They've also recently inked a non-exclusive three-year distribution agreement with Pennine Healthcare.

Pennine has an “established presence” in the UK orthopaedic market which should help to drive sales of Tissue’s bone and soft tissue products.

Original Article: Tissue Regenix CEO excited to soon be selling first products in UK

NEXT ARTICLE

More From BioPortfolio on "Tissue Regenix CEO excited to soon be selling first products in UK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...